Abstract
What is the definition of neurocritical care? Daniel F. Hanley from the Johns Hopkins University stated on this point: “Three important aspects of the word critical are time, physiology, and outcome” [1]. The role of time is strictly connected with the progression of the nervous system dysfunction, and with the observation that early treatment of some disorders limits the morbidity and mortality. Concerning the second word of the Hanley’s definition, it is well known that monitoring of key physiologic variables is essential in critical care. What is necessary to define is the physiologic parameters we have to follow for each type of disorder. Finally the outcome, that is the precise definition of the consequences of a given disease by sex, age, type of insult and so on.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Daniel F Hanley (1993) Neurocritical care for coma, intracranial pressure, head injury, and neoplasia. Commentary. Curr Opin Neurol 6: 829–830
Hauser WA (1990) Status epilepticus: epidemiologic considerations. Neurology 40[Suppl 2]: 9–13
DeLorenzo RJ, Pellock JM, Towne AR et al (1995) Epidemiology of status epilepticus. J Clin Neurophysiol 12: 316–325
Rabinowicz AL, Correale J, Bracht K et al (1995) Neuron-specific enolase is increased after nonconvulsive status epilepticus. Epilepsia 36: 475–479
DeGiorgio CM, Correale JD, Rabinowicz AL et al (1996) Neuron-specific enolase, a marker of acute neuronal injury is elevated in complex partial status epilepticus. Epilepsia 37: 606–609
Cranford RE, Leppik IE, Patrick B et al (1979) Intravenous phenytoin in acute treatment of seizures. Neurology 29: 1474–1479
Towne AR, Pellock JM, Daljin K et al (1994) Determinants of mortality in status epilepticus. Epilepsia 35(1): 27–34
Young GB, Jordan KG, Doig GS (1996) An assessment of nonconvulsive seizures in the intensive care unit using continuous EEG monitoring: An investigation of variables associated with mortality. Neurology 47: 83–89
Treiman DM, Meyers PD, Walton NY (1991) Response of overt versus subtle generalized convulsive status epilepticus to intravenous anticonvulsant therapy. (Abstract) Epilepsia 32 [Suppl]37: 93
Jordan KG, Young GB, Doig GS (1995) Delays in emergency department (ED) diagnosis and treatment of nonconvulsive status epilepticus (NCSE). (Abstract) Neurology 45[Suppl 4]: A346
Lowenstein DH, Alldredge BK (1993) Status epilepticus at an urban public hospital in the 1980s. Neurology 43: 483–488
Beghi E, Kurland LT, Mulder DW et al (1985) Guillain-Barré syndrome: Clinicoepidemiologic features and effect on influenza vaccine. Arch Neurol 27: 1053–1057
Johnson DE (1982) Guillain-Barré syndrome in the US Army. Arch Neurol 39: 21–24
Kennedy RH, Danielson MA, Mulder DW et al (1978) Guillain-Barré syndrome: A 42-year epidemiologic and clinical study. Mayo Clin Proc 53: 93–98
Ropper AH, Wijdicks EFM, Truax BT (1991) Guillain-Barré syndrome. FA Davis, Philadelphia
Hartung H-P, Pollard JD, Harvey GK et al (1995) Immunopathogenesis and treatment of the Guillain-Barré syndrome-part I and II. Muscle Nerve 18: 137–164
Rees JH, Soudain S, Gregson NA (1995) Campylobacter jejuni infection and Guillain-Barré syndrome. N Engl J Med 333: 1374–1379
Griffin JW, Ho TW-H (1993) The Guillain-Barré syndrome at 75: the Campylobacter connection. Ann Neurol 34: 125–127
Hafer-Macko C, Hsieh S-T, Li CY et al (1996) Acute motor axonal neuropathy: an antibody mediated attack on axolemma. Ann Neurol 40: 635–644
Yuki NT, Taki F, Inagaki T et al (1993) A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure. J Exp Med 178: 1771–1775
Arnason BGW, Soliven B (1993) Acute inflammatory demyelinating polyradiculoneuropathy. In: Dyck PJ, Thomas PK, Griffin JW et al (eds) Peripheral neuropathy, 3th edn. WB Saunders, Philadelphia, p 1437
Saida K (1996) The immunopathology of Guillain-Barré syndrome. Curr Opin Neurol 9: 329–333
Truax BT (1984) Autonomic disturbances in Guillain-Barré syndrome. Neurology 4: 462–466
Harati Y, Low PA (1990) Autonomic peripheral neuropathies: Diagnosis and clinical presentation. In: Appel SH (ed) Current Neurology. Year Book Medical Publishers, p 105
Loffel NB, Rossi LN, Mumenthaler M et al (1977) The Landry-Guillain-Barré syndrome: Complications, prognosis, and natural history in 123 cases. J Neurol Sci 33: 71–79
McKhann GM, Griffin JW, Cornblath DR et al (1988) The Guillain-Barré Syndrome Study Group: Plasmapheresis and Guillain-Barré syndrome: Analysis of prognostic factors and the effect of plasmapheresis. Ann Neurol 23: 347–353
French Cooperative Group on Plasma Exchange in Guillain-Barré syndrome (1987) Efficiency of plasma exchange in Guillain-Barré syndrome: Role of replacement fluids. Ann Neurol 22: 753–761
Osterman PO, Fagius J, Lundemo G et al (1984) Beneficial effects of plasma exchange in acute inflammatory polyradiculoneuropathy. Lancet 2: 1296–1299
van der Meché FGA, Schmitz PIM, The Dutch Guillain-Barré Study Group (1992) A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. N Engl J Med 326: 1123–1129
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag Italia, Milano
About this paper
Cite this paper
Savettieri, G. (1998). Critical Neurologic Dysfunctions: Status Epilepticus and Guillain-Barré Syndrome. In: Gullo, A. (eds) Anaesthesia, Pain, Intensive Care and Emergency Medicine - A.P.I.C.E.. Springer, Milano. https://doi.org/10.1007/978-88-470-2278-2_47
Download citation
DOI: https://doi.org/10.1007/978-88-470-2278-2_47
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-0007-0
Online ISBN: 978-88-470-2278-2
eBook Packages: Springer Book Archive